Back to Search Start Over

Differences in Colistin-resistantAcinetobacter baumanniiClinical Isolates Between Patients With and Without Prior Colistin Treatment

Authors :
Dokyun Kim
Yu Jin Park
Eun Jeong Yoon
Hyukmin Lee
Seok Hoon Jeong
Min Hyuk Choi
Duck Jin Hong
Jun Sung Hong
Dongeun Yong
Source :
Annals of Laboratory Medicine
Publication Year :
2018
Publisher :
Annals of Laboratory Medicine, 2018.

Abstract

Background The increasing morbidity and mortality rates associated with Acinetobacter baumannii are due to the emergence of drug resistance and the limited treatment options. We compared characteristics of colistin-resistant Acinetobacter baumannii (CR-AB) clinical isolates recovered from patients with and without prior colistin treatment. We assessed whether prior colistin treatment affects the resistance mechanism of CR-AB isolates, mortality rates, and clinical characteristics. Additionally, a proper method for identifying CR-AB was determined. Methods We collected 36 non-duplicate CR-AB clinical isolates resistant to colistin. Antimicrobial susceptibility testing, Sanger sequencing analysis, molecular typing, lipid A structure analysis, and in vitro synergy testing were performed. Eleven colistin-susceptible AB isolates were used as controls. Results Despite no differences in clinical characteristics between patients with and without prior colistin treatment, resistance-causing genetic mutations were more frequent in isolates from colistin-treated patients. Distinct mutations were overlooked via the Sanger sequencing method, perhaps because of a masking effect by the colistin-susceptible AB subpopulation of CR-AB isolates lacking genetic mutations. However, modified lipid A analysis revealed colistin resistance peaks, despite the population heterogeneity, and peak levels were significantly different between the groups. Conclusions Although prior colistin use did not induce clinical or susceptibility differences, we demonstrated that identification of CR-AB by sequencing is insufficient. We propose that population heterogeneity has a masking effect, especially in colistin non-treated patients; therefore, accurate testing methods reflecting physiological alterations of the bacteria, such as phosphoethanolamine-modified lipid A identification by matrix-assisted laser desorption ionization-time of flight, should be employed.

Details

ISSN :
22343814 and 22343806
Volume :
38
Database :
OpenAIRE
Journal :
Annals of Laboratory Medicine
Accession number :
edsair.doi.dedup.....d6b1793381abd7c06050eafb99818b2f